- Filed
- Nov 10, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2022 · Sep 30, 2022 | 78.68M sh |
| Shares Diluted | Q3 2022 · Sep 30, 2022 | 78.16M sh |
| Shares Diluted | Q3 2022 · Sep 30, 2021 | 76.48M sh |
| Shares Diluted | Q3 2022 · Sep 30, 2021 | 71.64M sh |
| Capex | Q3 2022 · Sep 30, 2022 | $1.31M |
| Capex | Q3 2022 · Sep 30, 2021 | $1.58M |
| Operating Cash Flow | Q3 2022 · Sep 30, 2022 | $4.43M |
| Operating Cash Flow restated | Q3 2022 · Sep 30, 2021 | $33.97M |
| Cash And Equivalents | Q3 2022 · Sep 30, 2022 | $588.82M |
| Cash And Equivalents | Q3 2022 · Dec 31, 2021 | $581.54M |
| Stockholders Equity | Q3 2022 · Sep 30, 2022 | $395.85M |
| Stockholders Equity | Q3 2022 · Jun 30, 2022 | $404.72M |
| Stockholders Equity | Q3 2022 · Dec 31, 2021 | $417.62M |
| Stockholders Equity restated | Q3 2022 · Sep 30, 2021 | $422.42M |
| Stockholders Equity restated | Q3 2022 · Jun 30, 2021 | $419.91M |
| Stockholders Equity restated | Q3 2022 · Dec 31, 2020 | −$96.78M |
| Current Liabilities | Q3 2022 · Sep 30, 2022 | $219.23M |
| Current Liabilities | Q3 2022 · Dec 31, 2021 | $187.81M |
| Total Liabilities | Q3 2022 · Sep 30, 2022 | $223.75M |
| Total Liabilities | Q3 2022 · Dec 31, 2021 | $191.05M |
| Current Assets | Q3 2022 · Sep 30, 2022 | $597.08M |
| Current Assets | Q3 2022 · Dec 31, 2021 | $591.28M |
| Total Assets | Q3 2022 · Sep 30, 2022 | $619.6M |
| Total Assets | Q3 2022 · Dec 31, 2021 | $608.67M |
| Eps Diluted | Q3 2022 · Sep 30, 2022 | −$0.30 |
| Eps Diluted | Q3 2022 · Sep 30, 2022 | −$0.77 |
| Eps Diluted | Q3 2022 · Sep 30, 2021 | −$0.09 |
| Eps Diluted restated | Q3 2022 · Sep 30, 2021 | −$1.17 |
| Eps Basic | Q3 2022 · Sep 30, 2022 | −$0.30 |
| Eps Basic | Q3 2022 · Sep 30, 2022 | −$0.77 |
| Eps Basic | Q3 2022 · Sep 30, 2021 | −$0.09 |
| Eps Basic restated | Q3 2022 · Sep 30, 2021 | −$1.17 |
| Sga Expense | Q3 2022 · Sep 30, 2022 | $20.47M |
| Sga Expense | Q3 2022 · Sep 30, 2022 | $53.28M |
| Sga Expense restated | Q3 2022 · Sep 30, 2021 | $11.73M |
| Sga Expense restated | Q3 2022 · Sep 30, 2021 | $42.32M |
| Rd Expense | Q3 2022 · Sep 30, 2022 | $18.19M |
| Rd Expense | Q3 2022 · Sep 30, 2022 | $52.46M |
| Rd Expense | Q3 2022 · Sep 30, 2021 | $12.33M |
| Rd Expense | Q3 2022 · Sep 30, 2021 | $43.57M |
| Net Income | Q3 2022 · Sep 30, 2022 | −$23.54M |
| Net Income | Q3 2022 · Sep 30, 2022 | −$60.44M |
| Net Income restated | Q3 2022 · Sep 30, 2021 | −$6.86M |
| Net Income restated | Q3 2022 · Sep 30, 2021 | −$83.55M |
| Operating Income | Q3 2022 · Sep 30, 2022 | −$24.28M |
| Operating Income | Q3 2022 · Sep 30, 2022 | −$61.63M |
| Operating Income restated | Q3 2022 · Sep 30, 2021 | −$6.9M |
| Operating Income restated | Q3 2022 · Sep 30, 2021 | −$29.43M |
| Revenue | Q3 2022 · Sep 30, 2022 | $88.43M |
| Revenue | Q3 2022 · Sep 30, 2022 | $268.43M |
| Revenue restated | Q3 2022 · Sep 30, 2021 | $79.46M |
| Revenue restated | Q3 2022 · Sep 30, 2021 | $241.81M |